Trial Information
Prediction of Recurrence in Advanced Gastric Cancer After Radical Resection by Circulating Tumor Cells (CTCs)
Inclusion Criteria:
- Having signed informed consent
- Age≥ 18 years old
- Histologically confirmed gastric adenocarcinoma
- Preoperative clinical examination and imaging indicating operable disease
- complete resection (R0 resection)
- D2 or D2+ resection
Exclusion Criteria:
- Other tumor type than adenocarcinoma
- Patients who have been given preoperative chemotherapy/chemoradiation.
- Staging investigations or intraoperative exploration indicating inoperable disease
- R1 or R2 resection
- D0 or D1 resection
- Patients unreliable for follow up
- Past history of malignancy
Type of Study:
Observational
Study Design:
Time Perspective: Prospective
Outcome Measure:
CTCs
Outcome Time Frame:
2 months
Safety Issue:
No
Principal Investigator
Lin Shen, MD, PhD
Investigator Role:
Principal Investigator
Investigator Affiliation:
Peking University
Authority:
China: Food and Drug Administration
Study ID:
CGOG5003
NCT ID:
NCT01848015
Start Date:
June 2013
Completion Date:
June 2016
Related Keywords:
- Gastric Cancer
- CTCs before and after gastrectomy
- Stomach Neoplasms
- Neoplastic Cells, Circulating